These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1944274)

  • 1. Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities.
    Zhang XK; Wills KN; Husmann M; Hermann T; Pfahl M
    Mol Cell Biol; 1991 Dec; 11(12):6016-25. PubMed ID: 1944274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive and negative modulation of Jun action by thyroid hormone receptor at a unique AP1 site.
    Lopez G; Schaufele F; Webb P; Holloway JM; Baxter JD; Kushner PJ
    Mol Cell Biol; 1993 May; 13(5):3042-9. PubMed ID: 8474460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proto-oncogenes c-fos and c-jun modulate thyroid hormone inhibition of human thyrotropin beta subunit gene expression in opposite directions.
    Bodenner DL; McClaskey JH; Kim MK; Mixson AJ; Weintraub BD
    Biochem Biophys Res Commun; 1992 Dec; 189(2):1050-6. PubMed ID: 1335239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.
    Salbert G; Fanjul A; Piedrafita FJ; Lu XP; Kim SJ; Tran P; Pfahl M
    Mol Endocrinol; 1993 Oct; 7(10):1347-56. PubMed ID: 8264664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers.
    McBride K; Nemer M
    Mol Cell Biol; 1998 Sep; 18(9):5073-81. PubMed ID: 9710591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of retinoic acid-induced inhibition of AP-1 activity by orphan receptor chicken ovalbumin upstream promoter-transcription factor.
    Lin F; Kolluri SK; Chen GQ; Zhang XK
    J Biol Chem; 2002 Jun; 277(24):21414-22. PubMed ID: 11934895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of c-fos gene expression by thyroid hormone and retinoic acid receptors.
    Perez P; Schönthal A; Aranda A
    J Biol Chem; 1993 Nov; 268(31):23538-43. PubMed ID: 8226882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong and prolonged induction of c-jun and c-fos proto-oncogenes by photodynamic therapy.
    Kick G; Messer G; Plewig G; Kind P; Goetz AE
    Br J Cancer; 1996 Jul; 74(1):30-6. PubMed ID: 8679454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.
    Sato H; Takeshita H; Furukawa M; Seiki M
    J Virol; 1992 Aug; 66(8):4732-6. PubMed ID: 1321269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathways in the induction of c-fos and c-jun proto-oncogenes by 3-methylcholanthrene.
    Ainbinder E; Bergelson S; Daniel V
    Recept Signal Transduct; 1997; 7(4):279-89. PubMed ID: 9633828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phorbol ester inhibition of rat gonadotropin-releasing hormone promoter activity: role of Fos and Jun in the repression of transcription.
    Bruder JM; Spaulding AJ; Wierman ME
    Mol Endocrinol; 1996 Jan; 10(1):35-44. PubMed ID: 8838143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. fos/jun repression of cardiac-specific transcription in quiescent and growth-stimulated myocytes is targeted at a tissue-specific cis element.
    McBride K; Robitaille L; Tremblay S; Argentin S; Nemer M
    Mol Cell Biol; 1993 Jan; 13(1):600-12. PubMed ID: 8417355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro.
    Kerppola TK; Luk D; Curran T
    Mol Cell Biol; 1993 Jun; 13(6):3782-91. PubMed ID: 8497279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phorbol ester-induced monocytic differentiation by dexamethasone is associated with down-regulation of c-fos and c-jun (AP-1).
    Hass R; Brach M; Kharbanda S; Giese G; Traub P; Kufe D
    J Cell Physiol; 1991 Oct; 149(1):125-31. PubMed ID: 1939341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional antagonism between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription.
    Ambrosino C; Cicatiello L; Cobellis G; Addeo R; Sica V; Bresciani F; Weisz A
    Mol Endocrinol; 1993 Nov; 7(11):1472-83. PubMed ID: 8114761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive regulation of the skeletal alpha-actin gene by Fos and Jun in cardiac myocytes.
    Bishopric NH; Jayasena V; Webster KA
    J Biol Chem; 1992 Dec; 267(35):25535-40. PubMed ID: 1460048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AP-1 (Fos-Jun) regulation by IP-1: effect of signal transduction pathways and cell growth.
    Auwerx J; Sassone-Corsi P
    Oncogene; 1992 Nov; 7(11):2271-80. PubMed ID: 1437149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression.
    Yoshioka K; Deng T; Cavigelli M; Karin M
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4972-6. PubMed ID: 7761434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AP-1 antagonizes thyroid hormone receptor action on the thyrotropin beta-subunit gene.
    Wondisford FE; Steinfelder HJ; Nations M; Radovick S
    J Biol Chem; 1993 Feb; 268(4):2749-54. PubMed ID: 8428949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.